The authors found that growth hormone (GH) response to edrophonium was
no different in 12 Alzheimer's disease patients than in eight healthy
elderly subjects. Previously reported differences could be due to
differences in gender or baseline GH concentrations between patients and
control subjects.Abstract Teaser